• norsk
    • English
  • norsk 
    • norsk
    • English
  • Logg inn
Vis innførsel 
  •   Hjem
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • Vis innførsel
  •   Hjem
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma

Brekke, Cecilie; Wang, Jian; Thuen, Marte; Gras Navarro, Andrea; Huuse-Røneid, Else Marie; Thorsen, Frits Alan; Poli, Aurélie; Zimmer, Jacques; Haraldseth, Olav; Lie, Stein Atle; Enger, Per Øyvind; Chekenya, Martha
Journal article, Peer reviewed
Thumbnail
Åpne
journal.pone.0108414.pdf (2.371Mb)
Permanent lenke
http://hdl.handle.net/11250/296433
Utgivelsesdato
2014
Metadata
Vis full innførsel
Samlinger
  • Institutt for sirkulasjon og bildediagnostikk [1013]
  • Publikasjoner fra CRIStin - NTNU [19849]
Originalversjon
PLoS ONE 2014, 9(9)   10.1371/journal.pone.0108414
Sammendrag
There are currently no established radiological parameters that predict response to immunotherapy. We hypothesised that

multiparametric, longitudinal magnetic resonance imaging (MRI) of physiological parameters and pharmacokinetic models

might detect early biological responses to immunotherapy for glioblastoma targeting NG2/CSPG4 with mAb9.2.27

combined with natural killer (NK) cells. Contrast enhanced conventional T1-weighted MRI at 761 and 1762 days posttreatment

failed to detect differences in tumour size between the treatment groups, whereas, follow-up scans at 3 months

demonstrated diminished signal intensity and tumour volume in the surviving NK+mAb9.2.27 treated animals. Notably,

interstitial volume fraction (ve), was significantly increased in the NK+mAb9.2.27 combination therapy group compared

mAb9.2.27 and NK cell monotherapy groups (p = 0.002 and p = 0.017 respectively) in cohort 1 animals treated with 1 million

NK cells. ve was reproducibly increased in the combination NK+mAb9.2.27 compared to NK cell monotherapy in cohort 2

treated with increased dose of 2 million NK cells (p,0.0001), indicating greater cell death induced by NK+mAb9.2.27

treatment. The interstitial volume fraction in the NK monotherapy group was significantly reduced compared to mAb9.2.27

monotherapy (p,0.0001) and untreated controls (p = 0.014) in the cohort 2 animals. NK cells in monotherapy were unable

to kill the U87MG cells that highly expressed class I human leucocyte antigens, and diminished stress ligands for activating

receptors. A significant association between apparent diffusion coefficient (ADC) of water and ve in combination NK+

mAb9.2.27 and NK monotherapy treated tumours was evident, where increased ADC corresponded to reduced ve in both

cases. Collectively, these data support histological measures at end-stage demonstrating diminished tumour cell

proliferation and pronounced apoptosis in the NK+mAb9.2.27 treated tumours compared to the other groups. In

conclusion, ve was the most reliable radiological parameter for detecting response to intralesional NK cellular therapy.
Utgiver
Public Library of Science
Tidsskrift
PLoS ONE

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit
 

 

Bla i

Hele arkivetDelarkiv og samlingerUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifterDenne samlingenUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifter

Min side

Logg inn

Statistikk

Besøksstatistikk

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit